Clinical Trial Update: Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care [Phase 4]

View source ↗

Summary

Phase 4 efficacy trial comparing Extended-Release Niacin/Lovastatin to usual care in patients with lipid disorders. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hyperlipidemia
• Mixed Dyslipidemia

Drugs mentioned

• Extended-Release Niacin/Lovastatin (niacin/lovastatin)

Snippet

Sponsor: In His Image | Conditions: Hyperlipidemia, Mixed Hyperlipidemia | Phase 4 | Status: COMPLETED